PA
ITCI

Perceptive Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Perceptive Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-800,600
Closed -$28.6M – 129
2019
Q4 		$28.6M Buy
+800,600
New +$9.61M 0.57% 41

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Perceptive Advisors's ITCI Position: Q2 2025 in Review

Perceptive Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 786,358 shares — an estimated $104M sold.

Perceptive Advisors first reported a position in ITCI in Q3 2017 and held it in 9 quarters. The position peaked at $119M in Q3 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Perceptive Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Perceptive Advisors sold 786,358 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $104M.
  • Perceptive Advisors first reported a position in Intra-Cellular Therapies Inc. in Q3 2017 and held it in 9 quarters.
  • Perceptive Advisors's Intra-Cellular Therapies Inc. position peaked at $119M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Perceptive Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.